| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.3M | -17.4% |
| Cost of Revenue | $4.8M | -31.9% |
| R&D Expense | $4.8M | -11.6% |
| SG&A Expense | $12.7M | -10.9% |
| Operating Income | $20.9M | -5.9% |
| Pre-tax Income | $47.9M | +98.7% |
| Income Tax | $7.0M | +98.6% |
| Net Income | $40.9M | +98.7% |
| EPS (Basic) | $5.66 | +85.0% |
| EPS (Diluted) | $5.13 | +95.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.8M | -84.6% |
| Accounts Receivable | $4.4M | -28.5% |
| Inventory | $358K | -19.6% |
| Current Assets | $22.7M | -65.6% |
| Total Assets | $239.8M | +207.2% |
| Current Liabilities | $6.3M | +1.8% |
| Stockholders' Equity | $230.8M | +221.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.4M | +14.4% |
| Capital Expenditures | $51K | -85.2% |
| Investing Cash Flow | -$190.0M | -1132.7% |
| Financing Cash Flow | $117.2M | +2267.0% |
| Free Cash Flow | $24.4M | +16.1% |